Veneto Eye Bank Foundation, Venice, Italy.
Ocul Surf. 2010 Jul;8(3):146-53. doi: 10.1016/s1542-0124(12)70225-2.
The therapeutic use of limbal cultures for the permanent regeneration of corneal epithelium in patients with limbal stem cell deficiency (LSCD) has been reported in many studies. According to the guidelines for good manufacturing practice (GMP), strictly regulated procedures and stringent quality control tests are now required to manipulate stem cells as "medicinal products" and make engraftment safer and eventually more successful. This paper describes techniques for optimal preparation of limbal stem cell grafts, including 1) a reliable impression cytology assay for the grading of LSCD, 2) culture methods that maintain high percentages of limbal stem cells, 3) the use of specific markers for the detection of corneal, conjunctival, and limbal stem cells, namely keratin 12, mucin 1, and DeltaNp63alpha, and 4) assays to assess the presence of contaminants, such as murine fibroblasts, endotoxins, mycoplasmae, and viral particles, in the cultured graft. The use of some of these assays allowed us to obtain a regenerated normal corneal epithelium in approximately 80% of 166 LSCD patients who received transplants from 2004 to 2008.
已有多项研究报告称,通过培养角膜缘干细胞(limbal stem cell, LSC),用于治疗因 LSC 缺乏而导致的角膜上皮持续性病变(limbal stem cell deficiency, LSCD),具有治疗作用。根据良好生产规范(Good Manufacturing Practice,GMP)准则,目前需要对作为“药品”的干细胞进行严格的规范操作和严格的质量控制检测,以提高移植物的安全性和成功率。本文介绍了制备角膜缘干细胞移植物的最佳技术,包括:(1)用于 LSCD 分级的可靠印迹细胞学检测;(2)维持高比例角膜缘干细胞的培养方法;(3)使用特定的标志物,用于检测角膜、结膜和角膜缘干细胞,如角蛋白 12、粘蛋白 1 和 DeltaNp63alpha;(4)检测污染物的方法,如鼠成纤维细胞、内毒素、支原体和病毒颗粒,这些污染物存在于培养的移植物中。在 2004 年至 2008 年间,我们对 166 名 LSCD 患者进行了移植治疗,其中约 80%的患者使用了其中一些检测方法,从而获得了再生的正常角膜上皮。